Abstract

To investigate the neuroimaging and clinical features associated with sleep-related epilepsy (SRE) in patients with focal cortical dysplasia (FCD) type II. Patients with histopathologically proven FCD type II were included from three epilepsy centers. SRE was defined according to the video EEG findings and seizure history. Cortical surface reconstruction and volume calculation were performed using FreeSurfer. The lesions were manually delineated on T1 volumetric MRI using the ITK-SNAP software. The lesion volumes were normalized by the intracranial volume of each patient. The lesions were classified as small or large by placing a threshold based on quantitative (whether the lesion was detected on MRI report) and qualitative (volume) criteria. A total of 77 consecutive patients were included. Of them, 36 had SRE and 41 had non-SRE. An earlier age of epilepsy onset, high seizure frequency, regional interictal EEG findings, and favorable surgical outcome were characteristic in both groups. Small lesions were defined as those having a volume <3,217 mm3. In total, 60.9% of the patients with SRE (25/41) had small FCD lesion, which was significantly higher than the non-SRE group (9/34, 26.5%, p = 0.005). Small lesion size was the only predictor significantly associated with SRE in the overall type II group by multivariate analyses (p = 0.016). Although the proportion of patients who had frontal FCD and SRE was higher than non-frontal FCD (54.5 vs. 27.3%, p = 0.043), the relationship between SRE and lesion location was not confirmed by multivariate analysis. Thalamic volume and seizure semiology were not statistically different between the SRE and non-SRE group. The significant association between lesion size and SRE was reproducible in type IIb and IIa subgroups. SRE is common in patients with FCD type II. Small FCD type II lesions are significantly associated with SRE. Although our findings cannot be applied to the entire spectrum of SRE, potential existence of small FCD lesions should be considered when evaluating patients with SRE, and utilization of all other supportive electroclinical information for lesion detection is highly desirable.

Highlights

  • Sleep-related epilepsy (SRE), described as most seizures occurring during sleep [1,2,3], represents up to 12% of patients with epilepsy

  • We investigate whether the patients with SRE demonstrates specific neuroimaging or clinical features compared to the non-SRE subgroup in a cohort of patients with histopathologically proven Focal cortical dysplasia (FCD) type II

  • We retrospectively reviewed the patients who underwent surgery and had histopathologically confirmed FCD type II from three different epilepsy centers: Second Affiliated Hospital of Zhejiang University (SAHZU), the Beijing Tiantan Hospital of Capital Medical University (BTH), and Cleveland Clinical Foundation (CCF)

Read more

Summary

Introduction

Sleep-related epilepsy (SRE), described as most seizures occurring during sleep [1,2,3], represents up to 12% of patients with epilepsy. Most of the patients with SRE have focal epilepsy [4]. Focal cortical dysplasia (FCD) type II is a major cause of pharmacoresistant extra-temporal epilepsy in patients undergoing epilepsy surgery [8, 9]. One previous study showed the existence of FCD type II increased the risk of SRE with respect to other histopathological substrates, regardless of its location [10]. Another study reported that SRE occurred more frequently in patients with MRI-negative FCD type II than the MRI-positive group [11]. The sleep–wake process modulates the electrophysiological activity generated by FCD type II, as revealed by intracranial EEG recordings, suggesting there is an interaction between seizure activity and the thalamocortical networks [4, 12]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call